Your browser doesn't support javascript.
loading
Urinary stone in infants; should vitamin D prophylaxis be stopped?
Akinci, Aykut; Karaburun, Murat Can; Kubilay, Eralp; Solak, Vahid Talha; Sanci, Adem; Soygur, Tarkan; Burgu, Berk.
Afiliación
  • Akinci A; Department of Pediatric Urology, Denizli State Hospital, Denizli, Turkey. Electronic address: aykut-akinci@hotmail.com.
  • Karaburun MC; Department of Urology, Acipayam State Hospital, Denizli, Turkey.
  • Kubilay E; Department of Urology, International Cyprus University, Cyprus.
  • Solak VT; Department of Urology, Kadirli State Hospital, Osmaniye, Turkey.
  • Sanci A; Department of Urology, Etlik City Hospital, Ankara, Turkey.
  • Soygur T; Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey.
  • Burgu B; Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey.
J Pediatr Urol ; 2024 Apr 16.
Article en En | MEDLINE | ID: mdl-38702222
ABSTRACT

BACKGROUND:

This study investigated the effect of the discontinuation of vitamin D supplementation on kidney stone formation in children under 2 years of age.

METHODS:

This study involved a retrospective analysis of two patient groups. The first group comprised postoperative patients who were stone-free, while the second group consisted of asymptomatic patients with kidney stones. The patients who discontinued vitamin D supplementation and those who continued were compared in terms of stone formation and stone size progression. The data collected included patient characteristics, stone size measurements, and laboratory results.

RESULTS:

The findings showed that the discontinuation of vitamin D supplementation was not associated with kidney stone formation or the progression of stone size in either group. For patients who were stone-free on ultrasonography 1 month after the operation, according to the 12-month ultrasonography evaluation, in the group that discontinued vitamin D, 42 (78%) patients had no stones, 6 (11%) patients had stones larger than 3 mm, and 6 (11%) patients had microlithiasis. However, in the group that continued vitamin D, 49 (72%) patients were stone-free, 10 (15%) patients had stones larger than 3 mm, and 9 (13%) patients had microlithiasis. There was no difference between the groups in terms of stone status at 12 months (p = 0.76). For patients with asymptomatic kidney stones, the initial stone sizes were similar between the groups (p = 0.74). During the 6th month of ultrasound, the changes in stone size were 1.76 ± 1.81 mm and 1.79 ± 1.75 mm for the two groups, respectively (p = 0.9). During the 12-month ultrasound measurement, the changes in stone size were 1.98 ± 2.93 mm and 2.60 ± 2.48 mm for the two groups, respectively (p = 0.09).

CONCLUSIONS:

We believe that more research is needed to make definitive recommendations regarding vitamin D prophylaxis in infants with kidney stones. Although the first objective of our study is not conclusively proven with the current findings, we recommend continued vitamin D prophylaxis in infants with urolithiasis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Urol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Urol Año: 2024 Tipo del documento: Article